Insider filing · ALNY
David E I Pyott
Director
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 57 filings in 24 months
ticker →
David E I Pyott sold $2.2M of Alnylam Pharmaceuticals (ALNY)
Executed Mar 24 2025, disclosed Mar 25 2025, 1 day later.
Value, as filed
$2.2M
7,440 sh × $299.00
Executed
Mar 24 2025
the trade date, as filed
Disclosed
Mar 25 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DPDavid E I Pyott (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $1.1M of ALNY (3,813 sh across 4 lots, as filed), executed Jun 1.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by David E I Pyott in ALNY
ALNYSALE
Alnylam Pharmaceuticals, Inc.
$1.1M3,813 sh across 4 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET